Showing results (151-160 of 166) with videos related to
Sort By:
Pageof 17
Journal of Clinical Psychopharmacology|August 1, 1992
Nortriptyline and weight change in depressed patients over 60C F Paradis, J A Stack, C J George, et al.Journal of Psychiatric Research|May 1, 2019
Getting to precision psychopharmacology: Combining clinical and genetic information to predict fat gain from aripiprazoleH Oughli, E J Lenze, A E Locke, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1991
Sleep in late-life recurrent depression. Changes during early continuation therapy with nortriptylineC F Reynolds, C C Hoch, D J Buysse, et al.Molecular Psychiatry|July 20, 2005
Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer diseaseR A Sweet, B Devlin, B G Pollock, et al.The American Journal of Psychiatry|December 1, 1994
Treatment of consecutive episodes of major depression in the elderlyC F Reynolds, E Frank, J M Perel, et al.The American Journal of Psychiatry|December 1, 1992
Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary reportC F Reynolds, E Frank, J M Perel, et al.Pharmacopsychiatry|October 28, 2015
Predicting Plasma Olanzapine Concentration Following a Change in Dosage: A Population Pharmacokinetic StudyT Tsuboi, R R Bies, T Suzuki, et al.JAMA|February 5, 1998
Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart diseaseS P Roose, F Laghrissi-Thode, J S Kennedy, et al.Circulation|September 1, 1988
Surgical survival benefits for coronary disease patients with left ventricular dysfunctionE P Bounous, D B Mark, B G Pollock, et al.The American Journal of Psychiatry|August 18, 1999
Three-year outcomes of maintenance nortriptyline treatment in late-life depression: a study of two fixed plasma levelsC F Reynolds, J M Perel, E Frank, et al.Pageof 17